CIK 0001420565
- Non-accelerated filer
- Smaller reporting company
Rein Therapeutics, Inc.
Sign in to watch- Ticker
- RNTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 134196017
- Phone
- +1 737-802-1989
- Business address
- 12407 N. MOPAC EXPY., SUITE 250 #390, AUSTIN, TX, 78758
- Former names
- Aileron Therapeutics, Inc., AILERON THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-30 | Wanstall Rick | Grant or award · Stock Option (right to buy) | +393,000 | 393,000 | ||
| 2022-03-22 | Wanstall Rick | Grant or award · Stock Option (right to buy) | +393,000 | 393,000 | ||
| 2021-06-15 | Wanstall Rick | Grant or award · Stock Option (right to buy) | +600,000 | 600,000 | ||
| 2020-06-23 | Wanstall Rick | Grant or award · Stock Option (right to buy) | +91,000 | 91,000 | ||
| 2020-01-31 | Wanstall Rick | Grant or award · Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2019-04-15 | Wanstall Rick VP, Finance and Operations | Grant or award · Stock Option (right to buy) | +59,000 | 59,000 |
Page 1 of 1 · 6 trades